+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 68Years
All Genders
ID07038408

Study Comparing Two Heart Artery Treatment Approaches Drug-Coated Balloon with Backup Bioresorbable Scaffold Versus Bioresorbable Scaffold Alone in Adults Aged 18 to 68 Undergoing PCI

Led by Ceric Sàrl · Updated on 2026-04-30

2256

Participants Needed

1

Research Sites

169 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two Leave nothing behind strategies for treating new coronary artery lesions in patients aged 18 to 68 with Chronic Coronary Syndromes CCS or Acute Coronary Syndrome ACS, including Non-ST-segment Elevation Myocardial Infarction NSTEMI and Unstable Angina. The study evaluates whether angioplasty with a Drug-Coated Balloon DCB plus bail-out Bioresorbable Scaffold BRS has similar clinical outcomes and angiographic results compared to BRS treatment alone over both early and long-term periods. Participants are randomly assigned to one of two treatment groups one group receives angioplasty starting with lesion preparation and treatment using the Mozec SEB DCB, with bail-out BRS if needed the other group receives BRS treatment with MeRes100. Both procedures involve balloon catheter use through femoral or brachial arteries and may include Optical Coherence Tomography OCT imaging if available. Bail-out BRS is deployed carefully with specific inflation timing and pressure guidelines. The study includes an angiographic substudy to measure in-segment net gain at 13 months. Participants will be followed for up to 5 years with scheduled visits including in-hospital and telephone check-ins at 1 month, 6 months, 1 year, and annually up to 5 years. Researchers will monitor the primary outcome of target-vessel failure TVF, which includes cardiovascular death, target-vessel heart attack, or revascularization, as well as secondary outcomes like bleeding events and other adverse clinical events. The study tracks both clinical and angiographic results to assess long-term efficacy and safety.

CONDITIONS

Brief Title

Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone

Research Team

D

DAVIDE CAPODANNO, Professor

C

CERC France

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here